Monday 12 May, 2025 08:06 PM
Site map | Locate Us | Login
   Newgen Software Tech gains after arm secures $1.63 million contract    Man Industries hits the roof after PAT rises nearly 3x YoY to Rs 68 crore in Q4    Piramal Pharma gains after receiving EIR for Turbhe facility from USFDA    Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations    K P R Mill Ltd leads losers in 'A' group    Bajaj Electricals soars after strong Q4 performance    Dr Reddys Lab jumps after Q4 PAT rises 22% YoY    Venkys (India) slides after Q4 PAT tumble 60% YoY to Rs 13 cr    Premier Explosives Ltd leads losers in 'B' group    TFCI jumps after Q4 PAT rises 48% YoY to Rs 30 cr    Volumes soar at C.E. Info Systems Ltd counter    TCS soars after signing digital transformation pact with Oman's largest insurer Dhofar Insurance    Yes Bank gains as Japan's SMBC to acquire 20% stake in landmark deal    Sun Pharmaceutical Industries Ltd eases for fifth straight session    Castrol India Ltd soars 1.91%, rises for third straight session 
Saravan Stocks
       
Profit and Loss
Aarti Pharmalabs Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
543748 INE0LRU01027 188.3314054 AARTIPHARM 0.39 6954.85 30.05 25.54 5
 Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
INCOME :     
Sales Turnover 1502.131511.25941.020.000.00
Excise Duty0.000.000.000.000.00
Net Sales1502.131511.25941.020.000.00
Other Income 11.011.282.510.000.00
Stock Adjustments 23.3691.2232.540.000.00
Total Income1536.501603.75976.070.000.00
EXPENDITURE :     
Raw Materials 775.33909.15484.200.000.00
Power & Fuel Cost82.9274.2243.430.000.00
Employee Cost 120.15113.9279.980.000.00
Other Manufacturing Expenses 100.9491.11164.690.000.00
Selling & Administrative Expenses 76.3482.9321.460.000.02
Miscellaneous Expenses 23.6522.800.010.000.00
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.00
Total Expenditure1179.331294.14793.780.000.02
Operating Profit357.16309.62182.300.00-0.02
Interest 16.6320.4911.340.000.00
Gross Profit340.53289.13170.960.00-0.02
Depreciation66.0155.7737.230.000.00
Profit Before Tax274.52233.36133.730.00-0.02
Tax46.0652.1322.500.000.00
Fringe Benefit tax0.000.000.000.000.00
Deferred Tax27.829.504.500.000.00
Reported Net Profit200.65171.73106.730.00-0.02
Extraordinary Items 0.000.000.030.000.00
Adjusted Net Profit200.65171.73106.700.00-0.02
Adjustment below Net Profit 0.000.00599.240.000.00
P & L Balance brought forward859.55705.95-0.02-0.020.00
Statutory Appropriations0.000.000.000.000.00
Appropriations 18.1318.130.000.000.00
P & L Balance carried down1042.07859.55705.95-0.02-0.02
Dividend18.1318.130.000.000.00
Preference Dividend0.000.000.000.000.00
Equity Dividend %60.0040.000.000.000.00
Dividend Per Share(Rs)3.002.000.000.000.00
Earnings Per Share-Unit Curr22.1418.954269.05-0.18-0.75
Earnings Per Share(Adj)-Unit Curr22.1418.954269.05-0.18-0.75
Book Value-Unit Curr178.92158.7449558.529.079.25
Book Value(Adj)-Unit Curr178.92158.7449558.529.079.25
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40800538
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd